Insights from Goldman Sachs and Parexel: Decoding Healthcare's Future: Investment, Clinical Research, and Regulatory Dynamics
Biopharma has been on a roller coaster for the past few years. Now, a more predictable global ecosystem, incredible innovation in science and technology, and a booming investment environment are opening-up exciting opportunities for large pharma and biotechs alike. Those are a few predictions from leaders at Parexel and Goldman Sachs. Tune in to learn more.
For more expert insights, visit https://www.parexel.com/insights
January 2024, San Francisco CA
Disclaimer: The views and opinions that the panelists express are their own and are for informational purposes only. They do not constitute a recommendation by Goldman Sachs Asset Management for you to take any action.